நாங்கள் இல் அஜாக்ஸ் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நாங்கள் இல் அஜாக்ஸ் ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நாங்கள் இல் அஜாக்ஸ் ஆரோக்கியம் Today - Breaking & Trending Today

Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman


Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman
Investment company hopes to create technology accelerator to speed bringing new innovations to market
March 12, 2021 Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to Hellman & Friedman (H&F) for approximately $1 billion. 
Hellman & Friedman is a global private equity firm with investments in high-quality growth businesses. It is partnering in the transaction with Ajax Health and Zeus Health to build the Cordis business. Ajax identifies and supports scaling up disruptive technologies in the healthcare space. Zeus Health is a platform focused on investing in and operating a portfolio of emerging medical technology companies. ....

United States , Hellman Friedman , Mike Kaufmann , Duke Rohlen , Hunter Philbrick , Cardinal Health , Zeus Health , Ajax Health , We At Ajax Health , Hf Cardinal Health , Cordis Accelerator , Zeus Healt , Executive Chairman Designate , ஒன்றுபட்டது மாநிலங்களில் , நரகத்தில் மனிதன் ப்ரைட்மேன் , மைக் காஃப்மந் , வேட்டைக்காரன் பில்ப்ரிக் , கார்டினல் ஆரோக்கியம் , ஜீயஸ் ஆரோக்கியம் , அஜாக்ஸ் ஆரோக்கியம் , நாங்கள் இல் அஜாக்ஸ் ஆரோக்கியம் , ஹ்ஃப் கார்டினல் ஆரோக்கியம் , கோர்டிஸ் முடுக்குப்பொறி , ஜீயஸ் குணமடைய ,

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman


Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
USA - English
Share this article
Share this article
DUBLIN, Ohio, March 12, 2021 /PRNewswire/  Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer s assumption of certain liabilities and seller s retention of certain working capital accounts. The transaction is expected to close in the first half of Cardinal Health s fiscal year 2022, subject to customary closing conditions and regulatory clearances.
Cordis has a long history of innovation in minimally-invasive cardiovascular technology, and we are confident that with H&F as its owner, Cordis will be well-positioned for growth, innovation and success, said Mike Kaufmann, CEO of Cardinal Health. Cardinal Health and H&F have a shared passion for delivering high-quality medical p ....

United States , Sarah Shew , Hellman Friedman , Mike Kaufmann , Duke Rohlen , Kevin Moran , Hunter Philbrick , Deutsche Bank Securities Inc , Jp Morgan Securities , Ajax Health , Meagher Flom , We At Ajax Health , Kirkland Ellis , Cardinal Health Form , Hf Cardinal Health , Investment Bank , Cardinal Health , Zeus Health , Cordis Accelerator , Executive Chairman Designate , Deutsche Bank Securities , Menlo Park , Healthquest Capital , Polaris Partners , ஒன்றுபட்டது மாநிலங்களில் , சாரா காட்டு ,